Cirrhosis is a chronic disease of the liver, showing characteristic features of liver fibrosis and scarring, along with diminished functioning over time. A lot of research is being carried out to ...

Researchers provide a conceptual overview of liver vasomics, including the classification of vascular phenotypes in the liver.   Chronic liver diseases are closely linked to complex hemodynamic ...

A comprehensive proteomic map of liver fibrosis progression and healing in two mouse models identifies etiology-specific extracellular matrix components, laying the foundation for targeted ...

Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a variably defined ...

Figure 1: a, Schedule of DMN administrations and HGF–HVJ liposome or PBS injections. Figure 3: a–c, Liver sections of rats after DMN administration. Sprague–Dawley rats 4–5 weeks old and ...

The biopsy findings of cirrhotic NAFLD and NASH are another area of investigation in pathology. Abdelmalek et al [120] documented that biopsy-proven NASH that has progressed to cirrhosis may no ...

Study highlights the role of the Nwd1 gene in liver disease, paving the way for new therapies and better liver health Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns. It is prevalent in 30% ...